Vulnerable groups in society have been hit harder by the COVID-19 pandemic Some vulnerable groups in society have been hit harder by the COVID-19 pandemic than less vulnerable groups. These include young people (up to 24 years) who have physical or mental problems or come from low-income families.
Reminders for booster jab and repeat vaccination against COVID-19 Adults who have not yet had a booster jab or repeat vaccination against COVID-19 will receive a reminder letter from RIVM, starting Friday 8 July 2022.
Operations postponed due to pandemic result in 320,000 healthy life years lost The COVID-19 pandemic caused over 305,000 operations to be postponed in 2020 and 2021 in the Netherlands.
BA.5 variant detected in the Netherlands The BA.5 variant of the coronavirus SARS-CoV-2 was detected for the first time in the Netherlands this week.
People with impaired immunity invited for repeat vaccination From 19 April on, people who have moderately or severely impaired immunity will receive their invitation for a repeat vaccination against COVID-19.
RIVM recalls fill needles for COVID-19 vaccination at supplier’s request As of today, RIVM is recalling the fill needles made by MLS/Sol-Millenium Europe as a precaution, following a safety alert from the supplier. This applies to the SOL-M™ Blunt Fill Needle (REF 110022, LOT 05103013).
RIVM launches study on coronavirus herd immunity RIVM has launched a large-scale study to investigate how many people have antibodies for the novel coronavirus (COVID-19).
Novel coronavirus found in wastewater The novel coronavirus that causes COVID-19 has been detected in wastewater in the Netherlands, according to RIVM research.
Additional measures novel coronavirus COVID-19 RIVM has advised the Dutch government that additional measures are needed throughout the Netherlands to prevent the spread of COVID-19.
Results of random sample test: 4% of hospital staff infected with coronavirus Nearly four per cent of the hospital staff examined in Brabant is infected with the novel coronavirus (COVID-19). A random sample test by RIVM between 6 and 9 March reveals this.